A Pilot Study to Evaluate the Therapeutic Effect of Dihydroartemisinin on Female Androgenetic Alopecia
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY
The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Androgenetic Alopecia (AGA) in female adults. The main question it aims to answer is: • Does DHA increase terminal hair follicles in the vertex area. Researchers will compare oral DHA plus topical minoxidil to topical minoxidil alone in female patients with AGA to see if DHA works to alleviate AGA. Participants will: * Receive oral DHA every day plus topical minoxidil or use topical minoxidil alone for 6 months. * Visit the clinic once every month for checkups and tests.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 40
Healthy Volunteers: f
View:
• Clinically diagnosed with androgenetic alopecia (AGA)
• No pregnancy plans within the next 6 months
Locations
Other Locations
China
Zhongshan Hospital Fudan University
RECRUITING
Shanghai
Contact Information
Primary
Lujuan GAO, MD, PhD
gao.lujuan@zs-hospital.sh.cn
86-021-64041990
Time Frame
Start Date: 2025-06
Estimated Completion Date: 2026-12
Participants
Target number of participants: 30
Treatments
Active_comparator: Intervention Arm
oral dihydroartemisinin (DHA) combined with topical minoxidil
Other: Control Arm
topical minoxidil alone
Related Therapeutic Areas
Sponsors
Leads: Shanghai Zhongshan Hospital